Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone (Q43797322)

26 November 2017

Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone (English)

1 reference

26 November 2017

Pines M

1

1 reference

26 November 2017

Domb A

2

1 reference

26 November 2017

Ohana M

3

1 reference

26 November 2017

Inbar J

4

1 reference

26 November 2017

Genina O

5

1 reference

26 November 2017

Alexiev R

6

1 reference

26 November 2017

Nagler A

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

26 November 2017

Biochemical Pharmacology

1 reference

26 November 2017

62

1 reference

26 November 2017

1221-1227

1 reference

26 November 2017

9

1 reference

The multifactorial etiology of graft-versus-host disease

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Systemic scleroderma. Clinical and pathophysiologic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Transcriptional activation of the alpha 1(I) procollagen gene in systemic sclerosis dermal fibroblasts. Role of intronic sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Glycosaminoglycans in scleroderma and scleredema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Collagenous abnormalities in the heart of the tight-skin mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Increased collagen synthesis and increased content of type VI collagen in myocardium of tight skin mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Halofuginone: a novel antifibrotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Halofuginone: an inhibitor of collagen type I synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Reduction in pulmonary fibrosis in vivo by halofuginone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Halofuginone--an inhibitor of collagen type I synthesis--prevents postoperative formation of abdominal adhesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Identification of Fibroblasts Responsible for Increased Collagen Production in Localized Scleroderma by In Situ Hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Insertion of retrovirus into the first intron of alpha 1(I) collagen gene to embryonic lethal mutation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Apoptosis and proliferation of fibroblasts during postnatal skin development and scleroderma in the tight-skin mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

The mast cell in fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900753-5

10.1016/S0006-2952(01)00753-5

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference